Latest News about LLY
Recent news which mentions LLY
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
July 09, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
From InvestorPlace
Tickers
LLY
From Motley Fool
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
From Motley Fool
S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone
July 09, 2024
From Benzinga
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
July 09, 2024
From Benzinga
Gold Falls Over 1%; HilleVax Shares Plunge
July 08, 2024
From Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
From InvestorPlace
Dow Turns Lower; Myomo Shares Jump
July 08, 2024
From Benzinga
Stock Market News From Amazon, Nike, McCormick, and More
July 08, 2024
From Motley Fool
From Benzinga
3 No-Brainer Stocks to Buy in July
July 08, 2024
From Motley Fool
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
From Benzinga
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
From InvestorPlace
What's Going On With Eli Lilly Shares Friday?
July 05, 2024
From Benzinga
GLP-1 Treatments Such As Wegvoy, Mounjaro Cut Obesity-Related Cancer Risks, Study Finds
July 05, 2024
From Benzinga
Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
July 05, 2024
Tickers
LLY
From Motley Fool
3 Highly Rated Biotech Stocks for Your July Buy List
July 05, 2024
From InvestorPlace
From InvestorPlace
From Benzinga
Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
July 04, 2024
Tickers
LLY
From Motley Fool
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
From InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
From Motley Fool
From Benzinga
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
July 03, 2024
From Benzinga
Top 3 Health Care Stocks That May Crash This Quarter
July 03, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.